Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOB | P27338 | 3/20 | 0.44 |
| ▸ | CSNK2A2 | P19784 | 1/20 | 0.43 |
| ▸ | CSNK2B | P67870 | 1/20 | 0.43 |
| ▸ | CSNK2A1 | P68400 | 1/20 | 0.43 |
| ▸ | CSNK2A3 | Q8NEV1 | 1/20 | 0.43 |
| ▸ | NPC1 | O15118 | 3/20 | 0.43 |
| ▸ | RAB9A | P51151 | 2/20 | 0.43 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.43 |
| ▸ | PKM | P14618 | 1/20 | 0.43 |
| ▸ | PARP10 | Q53GL7 | 1/20 | 0.42 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.42 |
| ▸ | CHRNB4 | P30926 | 1/20 | 0.42 |
| ▸ | CHRNA3 | P32297 | 1/20 | 0.42 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.42 |
| ▸ | PLA2G4B | P0C869 | 1/20 | 0.42 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.40 |
| ▸ | MAPT | P10636 | 2/20 | 0.40 |
| ▸ | PLK1 | P53350 | 1/20 | 0.40 |
| ▸ | MAOA | P21397 | 1/20 | 0.40 |
| ▸ | POLB | P06746 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8937391 | 1.00 | MAOB (0.44) | MAOBCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL8937383 | 1.00 | MAOB (0.44) | MAOBCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL8937336 | 0.92 | MAOB (0.48) | MAOBCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL8937333 | 0.92 | MAOB (0.48) | MAOBCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL8937340 | 0.92 | MAOB (0.48) | MAOBCSNK2A2CSNK2BCSNK2A1CSNK2A3 | |
| SCHEMBL8937470 | 0.86 | HPGD (0.45) | MAOBNPC1RAB9ASMN1; SMN2PKM | |
| SCHEMBL8937465 | 0.86 | HPGD (0.45) | MAOBNPC1RAB9ASMN1; SMN2PKM | |
| SCHEMBL8937458 | 0.86 | HPGD (0.45) | MAOBNPC1RAB9ASMN1; SMN2PKM | |
| SCHEMBL8937361 | 0.77 | HPGD (0.50) | MAOBRAB9APKMPARP10ALDH1A1 | |
| SCHEMBL8937315 | 0.77 | HPGD (0.50) | MAOBRAB9APKMPARP10ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-5559109-A | Method of treating a PAF-mediated pathology or for treating or preventing psoriasis, nephritis, asthma or shock by administering a PAF antagonist | SANKKO COMPANY, LIMITED (JP) | 1996-09-24 | — | — | US | disclosed |
| US-5556852-A | PLATELET ACTIVATING FACTOR ANTAGONISTS | SANKYO COMPANY, LIMITED (JP) | 1996-09-17 | — | — | US | disclosed |
| US-5369106-A | N-acryloylpiperazine derivatives, their preparation and their use of PAF antagonists | SANKYO COMPANY, LIMITED (JP) | 1994-11-29 | — | — | US | disclosed |
| US-5192766-A | Platelet activating factor antagonist | SANKYO COMPANY, LIMITED (JP) | 1993-03-09 | — | — | US | disclosed |